Kadeja Lefebvre was recently convicted for her illegal practice of medicine, which resulted in the tragic death of a patient, Amélie Champagne. On April 28, 2026, a Quebec court found Lefebvre guilty of diagnosing Lyme disease—a task reserved for licensed physicians—and prescribing treatments without proper credentials.
Amélie Champagne, only 22 years old, struggled with severe depression linked to her belief that she had Lyme disease. Her condition deteriorated after receiving a diagnosis from Lefebvre, who lacked the necessary medical license. In September 2022, Champagne tragically took her own life. This heartbreaking case has illuminated the dangers of unregulated naturopathic practices.
The Collège des médecins, Quebec’s regulatory body for medical professionals, had previously warned Lefebvre to cease performing acts that only licensed doctors are permitted to conduct. Despite these warnings, she continued to diagnose and propose treatment plans that included natural products and specific diets—actions that ultimately contributed to patient harm.
Key findings from the inquiry into Champagne’s death:
- Lefebvre was fined $15,000 for illegally practicing medicine.
- She was found guilty on three out of eleven charges related to her practice.
- The public inquiry led to 19 recommendations aimed at improving healthcare regulation and patient safety.
The case has prompted discussions about the need for stricter regulations in alternative medicine. But what does this mean for patients seeking naturopathic treatment? Many advocates argue that while natural remedies can be beneficial, they must be administered by qualified professionals who understand the complexities of diseases like Lyme disease.
Dino Halikas, a spokesperson for the Collège des médecins, emphasized the importance of regulation in healthcare: “On ne demande pas mieux que d’être encadrés et balisés.” This statement highlights a growing demand among health professionals and patients alike for clearer guidelines and accountability in alternative medicine practices.
As officials continue to assess the implications of this case, it remains clear that patient safety must be at the forefront of any discussion regarding healthcare regulation. The tragic loss of Amélie Champagne serves as a poignant reminder of the risks involved when unlicensed practitioners operate outside established medical frameworks.
Moving forward, stakeholders in both conventional and alternative medicine will need to engage in meaningful dialogue about how best to protect patients while respecting their right to choose diverse treatment options. The ongoing discussions following this conviction will likely shape future regulatory measures in Quebec and beyond.
